Adynxx is a technologies company that commercializes differentiated regenerative medical products which assist the body in the repair of human tissue. Co.'s subsidiary, Celleration, Inc. developed the MIST® Ultrasound Healing Therapy (MIST Therapy) therapeutic ultrasound platform for the treatment of acute and chronic wounds. MIST Therapy is a noncontact, low-frequency ultrasound delivered through a saline mist to the wound bed. Co. has a license in intellectual property related to certain placental based products for wound care and wound management, including those made from extracellular matrix derived from the human placenta, and Biovance® Amniotic Membrane Allograft. We show 10 historical shares outstanding datapoints in our ALQA shares outstanding history coverage, used to compute ALQA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ALQA market cap history over the course of time is important for investors
interested in comparing ALQA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ALQA versus a peer is one thing; comparing
ALQA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ALQA can fluctuate over the course of history.
With this page we aim to empower investors researching ALQA by allowing them to research the ALQA market cap history. |
Free ALQA Email Alerts:
Video: The Importance of Market Cap
